Habitat Use by Female Mallards in the Lower Mississippi Alluvial Valley

ABSTRACT Mallard (Anas platyrhynchos) populations in the lower Mississippi Alluvial Valley (LMAV), USA, historically averaged 1.6 million and represented the largest concentrations of wintering mallards in North America. Effective management of this wintering population requires current information on use of habitats. Accordingly, we employed radiotelemetry techniques to assess proportional use of habitats by female mallards during winters 2004–2005 and 2005–2006. We divided winters into 4 time periods defined by hunting seasons (FIRST, SPLIT, SECOND, and POST) and recorded diurnal and nocturnal locations. We examined variations in proportional use of habitats and use of areas closed to hunting due to effects of age (immature or ad), winter (2004–2005 or 2005–2006), time period (SECOND or POST), individual female, and all potential interactions of these effects, using locations recorded during the latter 2 time periods. We found that diurnal and nocturnal proportional use of habitats varied inconsistently among time periods and winters. Mean proportional use of forested wetlands ranged from 0.475 to 0.816 and from 0.428 to 0.764 during diurnal and nocturnal sampling periods, respectively. Diurnal proportional use of areas closed to hunting varied inconsistently among time periods and winters. Mean proportional use of areas closed to hunting ranged from 0.183 to 0.423 during diurnal sampling periods. Nocturnal use of areas closed to hunting varied inconsistently among female ages and time periods and among female ages and winters. Mean proportional use of areas closed to hunting ranged from 0.211 to 0.445 during nocturnal sampling periods. Our research suggests that forested wetlands in the LMAV provide important wintering habitats for female mallards; continued restoration and establishment of these habitats should benefit female mallards.     

The Enzymic Synthesis of Dihydropteroate and Dihydrofolate by Plasmodium berghei

SYNOPSIS. Cell-free extracts of the rodent malaria parasite Plasmodium berghei synthesized dihydropteroate (H₂pteroate) and dihydrofolate (H₂folate) from 2-amino-4-hydroxy-6-hydroxymethyl-7,8-dihydropteridine (hydroxymethyldihydropteridine) and p-aminobenzoate (pAB) or p-aminobenzoylglutamate (pABG). The reaction was demonstrated also in extracts of Plasmodium gallinaceum, Plasmodium lophurae and Plasmodium knowlesi, by the use of a microbiologic assay method and pABG as cosubstrate. Some of the properties of the enzymes involved were investigated in P. berghei preparations, utilizing a radioactive assay which measures the conversion of [7-¹⁴C]pAB to [¹⁴C]H₂pteroate. Apparent K_m values of 0.28 μM for [7-¹⁴C]pAB, 0.037 mM for pABG and 0.8 μM for hydroxymethyldihydropteridine were obtained. The reaction had absolute requirements for ATP and Mg⁺⁺, and was stimulated by dithiothreitol. The enzymes required for the reaction were eluted together from Sephadex G-200 columns in a molecular weight range of 200,000–250,000. In bacteria hydroxymethyldihydropteridine is converted 1st by a pyrophosphokinase to pyrophosphorylmethyldihydropteridine, and this compound is then condensed with pAB to form H₂pteroate by H₂pteroate synthetase. Both enzymic activities were demonstrated in P. berghei preparations and separated by DEAE-Sephadex chromatography. The enzymic synthesis of H₂pteroate by P. berghei is inhibited by several sulfonamides and diaminodiphenylsulfone (DDS). The latter compound is shown to be competitive with pAB, with a K_i value of 0.38 μM; pABG is also a competitive inhibitor. These data establish an enzymic basis of support for the evidence obtained in vivo which indicate that malaria synthesize their folate cofactors de novo. It is suggested that the antimalarial action of sulfonamides and DDS is due to their inhibition of plasmodial H₂pteroate synthetase.     

Involvement of Glucocorticoids in the Development of the Secondary Palate

Genetic differences between various inbred strains of mice in the levels of glucocorticoid receptors embryonic in maxillary mesenchyme cells appear to be reflected in the magnitude of the responses to steroids in these cells. High levels of glucocorticoids cause significant growth inhibition in maxillary mesenchyme cells with subsequent alterations in the production of extracellular matrix components. The presence of higher levels of cytoplasmic glucocorticoid receptor proteins may be one factor which could predispose those strains such as A/J to a greater inhibition of craniofacial growth in vivo by glucocorticoids and therefore increase the frequency of cleft palate production. Furthermore, women with infertility treated with glucocorticoids to support pregnancy give birth to infants with a marked decrease in birth weight [98]. Pharmacologic doses of glucocorticoids can also cause a dramatic reduction in the growth of a number of fetal tissues in mice and humans. In fact, there is evidence that glucocorticoids may be a causative factor in the production of cleft palate in primates [52]. The nature of the molecular elements which determine the biochemical and physiologic responses to glucocorticoids in the palate still remains largely unknown. Although in the mouse there is some evidence to suggest that the major histocompatibility locus (H-2) might be involved, the level(s) at which this control is exerted is unknown. It is possible that this locus may regulate in some manner the level of glucocorticoid receptors and the response to glucocorticoids in the secondary palate. Moreover, there is evidence to suggest that other genes distinct from, but closely linked to the H-2 locus may be important in determining both the strain-dependent differences in susceptibility to glucocorticoid-induced cleft palate and the intracellular levels of cyclic AMP in the secondary palate. It is also apparent that glucocorticoids in conjunction with other hormones or growth factors such as epidermal growth factor and agents which regulate cyclic nucleotide metabolism are essential for the normal development of the secondary palate. Excesses or deficiencies in either the level of these growth regulators and/or in their receptors in specific fetal tissues at defined periods in development are likely to lead to certain fetal malformations. Definition and integration of the genetic, biochemical, and endocrine factors which are involved in the control of cellular growth as influenced by alterations in the composition of cell surface and extracellular matrix components should provide some insights into the events associated with normal palatogenesis.     

Partial Purification and Characterization of Naegleria fowleriβ-Glucosidase1

Naegleria fowleri cells, grown axenically, contain high levels of β-D-glucosidase which catalyzes the hydrolysis of 4-methylumbelliferyl-β-D-glucopyranoside (4MUGlc) (K_m, 0.9 mM), octyl-β-D-glucoside (K_m, 0.17 mM), and p-nitrophenyl-β-D-glucopyranoside at relative rates of 1.00, 2.88, and 1.16, respectively (substrate concentration, 3.0 mM). When the amebae are subjected to freeze-thawing, sonication, and centrifugation (100,000 g, 1 h), 85% of the β-glucosidase activity appears in the supernatant fraction. The β-glucosidase was purified 40-fold (34% yield) using a combination of chromatographic steps involving DE-52 cellulose, concanavalin A-Sepharose, and hydroxylapatite followed by isoelectric focusing. The predominant soluble β-D-galactosidase activity in the Naegleria extract copurifies with the β-D-glucosidase; the two activities have the same isoelectric point (pI, 6.9), similar heat stabilities, are both inhibited by lactobionic acid (K_i, 0.40 mM), and exhibit optima at pH 4.5, indicating that they are probably the same enzyme. The Naegleriaβ-D-glucosidase has an apparent molecular weight of 66,000, a Stokes radius of 25 Å, and a sedimentation coefficient of 4.2S. The β-glucosidase is not inhibited by conduritol β-epoxide or galactosylsphingosine but is completely inhibited by 1.25 mM bromo conduritol β-epoxide. The latter compound, when present in the growth medium, inhibits the growth of the organism and profoundly alters its ultrastructure, the main effect being the apparent inhibition of cytokinesis and the generation of multinucleate cells. The issue of the role of the β-glucosidase in the metabolism of the ameba and its possible role in pathogenic mechanisms are discussed.